PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Role of erythropoietin in prevention of amikacin-induced nephropathy.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22322815 ↗2012Reported benefit

Role of erythropoietin in prevention of amikacin-induced nephropathy.

RatChemical/toxinSprague-DawleyFemalen = 28 rats distributed equally into 4 groups (7 per group)Intraperitoneal2,000 IU/kgPretreatment before amikacin

Model: Amikacin-induced nephropathy (1.2 g/kg intraperitoneally)

Blood urea nitrogen rose from 13.1 plus or minus 0.4 mg/dL in saline controls to 26.6 plus or minus 3.9 mg/dL with amikacin (p < 0.01) and was significantly improved to 15.9 plus or minus 0.9 mg/dL with erythropoietin pretreatment, with marked reduction in histological tubular necrosis.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.